Stay updated with breaking news from Peter Radovich. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report)’s stock price reached a new 52-week low during mid-day trading on Thursday . The company traded as low as $23.14 and last traded at $23.47, with a volume of 36618 shares changing hands. The stock had previously closed at $24.02. Analyst Ratings Changes MIRM has been the […]
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report)’s stock price hit a new 52-week low during trading on Thursday . The company traded as low as $23.14 and last traded at $23.47, with a volume of 36618 shares traded. The stock had previously closed at $24.02. Wall Street Analysts Forecast Growth A number of equities […]
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) COO Peter Radovich sold 4,303 shares of Mirum Pharmaceuticals stock in a transaction on Monday, March 25th. The stock was sold at an average price of $25.80, for a total transaction of $111,017.40. Following the sale, the chief operating officer now directly owns 29,013 shares of the […]
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) COO Peter Radovich sold 4,303 shares of the firm’s stock in a transaction dated Monday, March 25th. The stock was sold at an average price of $25.80, for a total value of $111,017.40. Following the completion of the transaction, the chief operating officer now owns 29,013 shares […]
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) – Equities researchers at HC Wainwright dropped their FY2023 EPS estimates for Mirum Pharmaceuticals in a research note issued on Tuesday, February 27th. HC Wainwright analyst E. Arce now forecasts that the company will earn ($2.44) per share for the year, down from their previous estimate of ($2.13). […]